Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: Eur J Endocrinol. 2020 Dec;183(6):R185–R196. doi: 10.1530/EJE-20-0863

Table 1:

Expected biochemical and clinical sequelae of treatments for primary aldosteronism including: curative adrenalectomy for unilateral disease, non-curative unilateral adrenalectomy for bilateral disease, MR antagonist therapy, and dietary sodium restriction.

Parameters Curative Adrenalectomy for Unilateral Disease Non-curative Unilateral Adrenalectomy for Bilateral Disease MR Antagonist Therapy Dietary Sodium Restriction
Aldosterone ↓↓
Renin ↑↑ ↑↑ ↑↑
ARR ↓↓
Potassium
Base Excess/ Alkalosis
eGFR
Blood Pressure ↓↓
Risk for Incident Cardiovascular and Kidney Disease * unknown * #
*

Observations from longitudinal cohort studies comparing curative adrenalectomy with MR antagonist therapy

#

Observations from population-based studies evaluating dietary sodium restriction in essential hypertension